Clinical utility of 2',5'-oligoadenylate synthetase activity measurement: Using whole blood as a highly sensitive method to detect the effects of IFN

被引:2
|
作者
Uno, Kazuko
Suginoshita, Yoshiki
Kakimi, Kazuhiro
Moriyasu, Yasunori
Nakano, Koji
Nakamura, Naoto
Fujita, Toshio
Horino, Yoshihiro
Sato, Takayuki
Kishida, Tsunataro
机构
[1] Louis Pasteur Ctr Med Res, Sakyo Ku, Kyoto 6068225, Japan
[2] Kyoto Univ, Fac Med, Dept Gastroenterol & Hepatol, Kyoto, Japan
[3] Kyoto Prefectural Univ, Dept Internal Med 1, Kyoto 606, Japan
[4] Kyoto Prefectural Univ, Dept Anesthesia, Kyoto 606, Japan
[5] Faloco Biosyst, Kyoto, Japan
[6] Sumitomo Pharmaceut, Osaka, Japan
关键词
2'; 5'-oligoadenyrate synthetase; whole blood; IFN; viral diseases; autoimmune diseases; weak IFN signal;
D O I
10.1016/j.jviromet.2006.05.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Research progress on the pleiotropic effects of interferons (IFN) has thus far required detecting responses by weak IFN signals. The, activity of 2',5'-oligoadenylate synthetase (2-5OAS) is a valuable indicator in the prognosis and IFN treatment of patients with viral diseases such as hepatitis B and C. Although serum samples generally are used to measure enzyme activity, their values depend on the exact conditions under which blood is stored and the degree of haemolysis that occurs during blood drawing or serum separation. This study presents an improved method of evaluating 2-5OAS activity by using whole blood samples containing heparin, which are frozen and then thawed, instead of serum samples. This method is more reliable, convenient, and 50-100 times more sensitive than the conventional methods of measuring serum 2-5OAS activity. The reliability and sensitivity of this improved method enables detection of the effects of low doses of oral IFN administration or changes in the IFN and cytokine system by infection or autoimmune diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
  • [1] Induction of blood 2′,5′-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-τ
    Nakajima, A
    Sokawa, Y
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (03): : 397 - 402
  • [2] A Modified Coupled Spectrophotometric Method to Detect 2-5 Oligoadenylate Synthetase Activity in Prostate Cell Lines
    Bhosle, Sushma M.
    Hunt, Aisha
    Chaudhary, Jaideep
    BIOLOGICAL PROCEDURES ONLINE, 2016, 18
  • [3] A Modified Coupled Spectrophotometric Method to Detect 2-5 Oligoadenylate Synthetase Activity in Prostate Cell Lines
    Sushma M. Bhosle
    Aisha Hunt
    Jaideep Chaudhary
    Biological Procedures Online, 2016, 18
  • [4] Sponge (2′,5′)oligoadenylate synthetase activity in the whole sponge organism and in a primary cell culture
    Kelve, M
    Kuusksalu, A
    Lopp, A
    Reintamm, T
    JOURNAL OF BIOTECHNOLOGY, 2003, 100 (02) : 177 - 180
  • [5] Effects of specific mutations in active site motifs of 2′,5′-oligoadenylate synthetase on enzymatic activity
    Yamamoto, Y
    Sono, D
    Sokawa, Y
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (03): : 337 - 344
  • [6] 2',5'-oligoadenylate synthetase activity and T cell subset in the cerebrospinal fluid and peripheral blood of aseptic meningitis
    Sakatoku, H
    Inoue, M
    Kojima, M
    Azuma, E
    Komada, Y
    Zhou, YW
    Zhang, SL
    Sakurai, M
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 48 - 53
  • [7] MODULATION OF 2'5' OLIGOADENYLATE SYNTHETASE (2,5A)ACTIVITY AND INTERFERON (IFN) BINDING IN PATIENTS (PTS) WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) UNDERGOING IFN THERAPY
    ROSENBLUM, MG
    MAXWELL, BL
    TALPAZ, M
    GUTTERMAN, JU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 230 - 230
  • [8] 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY IN PERIPHERAL-BLOOD LYMPHOCYTES AS A CLINICAL MARKER IN INTERFERON THERAPY FOR CHRONIC HEPATITIS-B
    FURUTA, M
    AKASHI, K
    NAKAMURA, Y
    MATSUMOTO, K
    YAMAGUCHI, H
    TAKAMATSU, S
    SHIMIZU, T
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (01): : 111 - 119
  • [9] SERUM INTERFERON LEVEL AND (2'-5')OLIGOADENYLATE SYNTHETASE-ACTIVITY IN LYMPHOCYTES DURING CLINICAL INTERFERON APPLICATION
    LODEMANN, E
    NITSCHE, EM
    LANG, MH
    GEREIN, V
    ALTMEYER, P
    HOLZMANN, H
    KORNHUBER, B
    JOURNAL OF INTERFERON RESEARCH, 1985, 5 (04): : 621 - 628
  • [10] Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: Relationship to the antiviral effect of IFN-alpha
    Pawlotsky, JM
    Hovanessian, AG
    RoudotThoraval, F
    Robert, N
    Bouvier, M
    Babany, G
    Duval, J
    Dhumeaux, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) : 320 - 324